US 7592343
Pyridazine-piperazine compounds and their use as stearoyl-CoA desaturase inhibitors
granted A61KA61K31/501A61P
Quick answer
US patent 7592343 (Pyridazine-piperazine compounds and their use as stearoyl-CoA desaturase inhibitors) held by Xenon Pharmaceuticals Inc. expires Mon Sep 17 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Xenon Pharmaceuticals Inc.
- Grant date
- Tue Sep 22 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 17 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K31/501, A61P, A61P1/06, A61P1/16